| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/28/2010 | CN101697966A Application of furanodiene in preparation of medicaments for treating diseases caused by viruses |
| 04/28/2010 | CN101697961A New cefmenoxime hydrochloride preparation for drug administration by injection and preparation method thereof |
| 04/28/2010 | CN101697959A Potassium sodium dehydroandrographolide succinate and sodium chloride injection and preparation method thereof |
| 04/28/2010 | CN101697775A Traditional Chinese medicine feed additive for treating animal dysentery and diarrhea |
| 04/28/2010 | CN101697738A Method for continuously extracting antibactial substances and antioxidant substances from pyrolignucs acid |
| 04/27/2010 | USRE41279 made by combining aqueous composition containing visual indicator and organic components and aqueous solution of salt of chlorous acid, preferably alkali metal chlorite; materials are blended into viscous material containing emollient package which generates active antimicrobial chlorine dioxide |
| 04/27/2010 | USRE41278 useful to alleviate or improve various cosmetic conditions and dermatological disorders, including changes or damage to skin, nail and hair associated with intrinsic aging and/or extrinsic aging, as well as changes or damage caused by extrinsic factors |
| 04/27/2010 | USRE41277 protein D is an Ig receptor for human IgD and has an apparent molecular weight of 42,000; protein D can be detected in all of 116 encapsulated and non-encapsulated isolates of H. influenzae studied |
| 04/27/2010 | US7705148 substituted diaminopyrimidine compounds having HIV inhibiting properties; reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate (4-cyano, 2-pyrimidine- aniline derivative; reaction with acrylonitril |
| 04/27/2010 | US7705129 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 04/27/2010 | US7705016 administering small molecule capable of inhibiting CPT1(carnitine palmitoyl transferase1) is 2-tetradecylglydate (TDGA) or (R)-N-(tetradecylcarbamoyl)-aminocarnitine |
| 04/27/2010 | US7705015 Substituted pyrroline kinase inhibitors |
| 04/27/2010 | US7704976 Promoting repair of skin and mucous membrane tissues, the product of the present invention exhibits unique effects for controlling inflammation, damage, infection, and exudation; side effect reduction; topical administration |
| 04/27/2010 | US7704965 Methods and materials for treating human papillomavirus infections |
| 04/27/2010 | US7704957 For therapy of AIDS |
| 04/27/2010 | US7704924 Library of compounds comprising pyrrolobenzodiazepine moieties |
| 04/27/2010 | US7704526 Sustained release composition for oral administration of drugs |
| 04/27/2010 | US7704514 Vaccines |
| 04/27/2010 | US7704509 Producing an infectious, self-replicating, recombinant human parainfluenza viral particle for use in developing vaccine or preventative against respiratory tract infections |
| 04/27/2010 | US7704505 preventing a respiratory syncytial virus (RSV) infection which is MAb1129 by administering to a human in need thereof an effective amount of a humanized anti-RSV antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody |
| 04/27/2010 | US7704497 Molecules with extended half-lives, compositions and uses thereof |
| 04/27/2010 | CA2449180C Viral polymerase inhibitors |
| 04/27/2010 | CA2437524C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/27/2010 | CA2433067C An improved method for preparation of cefuroxime axetil |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor |
| 04/27/2010 | CA2372400C Expression and export of interferon-alpha proteins as fc fusion proteins |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2303202C Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 04/27/2010 | CA2293692C Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/27/2010 | CA2222129C A method for producing influenza hemagglutinin multivalent vaccines |
| 04/27/2010 | CA2195653C Cells bearing cd4 decoy receptors and related molecules and methods |
| 04/27/2010 | CA2179909C Ligand that binds fas antigen |
| 04/22/2010 | WO2010045381A2 Antimicrobial agents that target bacterial vkor |
| 04/22/2010 | WO2010045281A2 Stable aqueous formulations of water insoluble or poorly soluble drugs |
| 04/22/2010 | WO2010045266A1 Therapeutic antiviral peptides |
| 04/22/2010 | WO2010044919A2 Smallpox dna vaccine and the antigens therein that elicit an immune response |
| 04/22/2010 | WO2010044679A1 Anti-infective formulation and methods of use |
| 04/22/2010 | WO2010044474A1 Therapeutic agent for hepatitis c |
| 04/22/2010 | WO2010044390A1 Viral infection therapeutic drug containing polyalkyleneimine |
| 04/22/2010 | WO2010044103A1 Pharmaceutical composition for therapeutic or prophylactic treatment of bacterial infections and associated diseases |
| 04/22/2010 | WO2010044042A1 Antimicrobial compositions |
| 04/22/2010 | WO2010043893A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| 04/22/2010 | WO2010043867A1 Pyrrolo [2, 3-d] pyrimidines as inhibitors of hsp90 |
| 04/22/2010 | WO2010043865A1 Inhibitors of hsp90 |
| 04/22/2010 | WO2010043842A1 Staphylococcus protein essential for growth |
| 04/22/2010 | WO2010043714A1 Tricyclic nitrogen compounds used as antibacterials |
| 04/22/2010 | WO2010043696A1 Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus |
| 04/22/2010 | WO2010043230A1 Multiligand constructs |
| 04/22/2010 | WO2010043155A1 Novel purpurone-type alkaloids, process for their preparation, and their usage as medications |
| 04/22/2010 | WO2010043046A1 Peptide inhibitors of type iii secretion |
| 04/22/2010 | WO2010043039A1 Combination adjuvant formulation |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | WO2010023725A9 Novel compound signamycin, method for production thereof, and use thereof |
| 04/22/2010 | WO2010012466A8 Antitumor properties of no modified protease inhibitors |
| 04/22/2010 | WO2009155379A3 Artemisinin and derivatives thereof as antivirals |
| 04/22/2010 | WO2009151646A3 Non-invasive diagnostic agents and methods of diagnosing infectious disease |
| 04/22/2010 | WO2009043450A8 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 04/22/2010 | WO2009034346A8 Anti-bacterial agents |
| 04/22/2010 | WO2008142055A3 Antiviral agents |
| 04/22/2010 | US20100099776 Oily suspension of atovaquone |
| 04/22/2010 | US20100099754 5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same |
| 04/22/2010 | US20100099745 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors |
| 04/22/2010 | US20100099729 Nitric oxide donor compounds |
| 04/22/2010 | US20100099718 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| 04/22/2010 | US20100099710 Src family kinase inhibitors |
| 04/22/2010 | US20100099695 HCV NS3 Protease Inhibitors |
| 04/22/2010 | US20100099674 Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria |
| 04/22/2010 | US20100099672 Methods for treating hepatitis c |
| 04/22/2010 | US20100099643 Fused Pentacyclic Polyethers |
| 04/22/2010 | US20100099634 Macrolide compounds endowed with antiinflammatory activity |
| 04/22/2010 | US20100099625 Bio-security system |
| 04/22/2010 | US20100099614 Antimicrobial Peptides and Methods of Use |
| 04/22/2010 | US20100099612 treating cancer responsive to interferon alpha therapy; the protein is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b) |
| 04/22/2010 | US20100099600 Candidates against infection |
| 04/22/2010 | US20100098776 Soap-based liquid wash formulations with enhanced deposition of antimicrobial agents |
| 04/22/2010 | US20100098750 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/22/2010 | US20100098737 methods and compositions for delivery of glycopeptide antibiotics to medical device surfaces |
| 04/22/2010 | US20100098733 Nitric oxide releasing particles for oral care applications |
| 04/22/2010 | US20100098725 Methods for cultivating cells, propagating and purifying viruses |
| 04/22/2010 | US20100098724 Immunoenhacer-linked oligomeric hiv vaccines |
| 04/22/2010 | US20100098723 Vaccine compositions against infectious pathologies for mammals |
| 04/22/2010 | US20100098722 Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use |
| 04/22/2010 | US20100098718 Nucleic acid vectors for immunization |
| 04/22/2010 | US20100098697 Chlamydia trachomatis antigens |
| 04/22/2010 | US20100098681 Dimeric high affinity egfr constructs and uses thereof |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098661 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 04/22/2010 | US20100098660 Method of treating tuberculosis with interferons |
| 04/22/2010 | US20100098642 Optimised formulation of tobramycin for aerosolization |
| 04/22/2010 | DE202004021680U1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition |
| 04/22/2010 | CA2822167A1 Pharmaceutical topical compositions |
| 04/22/2010 | CA2740728A1 Therapeutic antiviral peptides |
| 04/22/2010 | CA2740560A1 Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus |
| 04/22/2010 | CA2740554A1 Multiligand constructs |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | CA2739701A1 Antimicrobial compositions |
| 04/22/2010 | CA2739551A1 Dengue virus neutralizing antibodies and uses thereof |
| 04/22/2010 | CA2737352A1 Combination adjuvant formulation |
| 04/22/2010 | CA2736335A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |